Hyperphosphorylation at serine 199/202 of tau factor in the gerbil hippocampus after transient forebrain ischemia

Biochemical and Biophysical Research Communications

Volumn 347, Issue 1, 2006, Pages 273-278

  Morioka, Motohiro ^a   Kawano, Takayuki ^a   Yano, Shigetoshi ^a   Kai, Yutaka ^a   Tsuiki, Hiromasa ^a   Yoshinaga, Yutaka ^a   Matsumoto, Jun ^a   Maeda, Tatsumi ^a   Hamada, Jun ichiro ^b   Yamamoto, Hideyuki ^a   Fukunaga, Kohji ^c   Kuratsu, Jun ichi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Hippocampus; Ischemia; Phosphorylation; Tau factor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALANINE; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OLOMOUCINE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RECOMBINANT PROTEIN; SERINE; TAU PROTEIN; TRANSACTIVATOR PROTEIN; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GERBIL; HIPPOCAMPUS; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; APOPTOSIS; BINDING SITES; BRAIN ISCHEMIA; GERBILLINAE; HIPPOCAMPUS; MALE; PHOSPHORYLATION; PROTEIN BINDING; REPERFUSION INJURY; SERINE;

GERBILLINAE;

EID: 33745748597     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.06.096     Document Type: Article

References (38)

1. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239 (1982) 57-69
2. Kawano T., Fukunaga K., Morioka M., et al. Decreased Akt activity is associated with activation of Forkhead transcription factor following transient forebrain ischemia in gerbil hippocampus. J. Cereb. Blood Flow Metab. 22 (2002) 926-934
3. Morioka M., Fukunaga K., Hasegawa S., et al. Activities of calcineurin and phosphatase 2A in the hippocampus after transient forebrain ischemia. Brain Res. 828 (1999) 135-144
4. 2+/calmodulin-dependent protein kinase II and calcineurin in the hippocampus of rat brain after transient forebrain ischemia. J. Neurochem. 58 (1992) 1798-1809
5. Morioka M., Hamada J., Ushio Y., et al. Potential role of calcineurin for brain ischemia and traumatic injury. Prog. Neurobiol. 56 (1999) 1-30
6. Yano S., Morioka M., Fukunaga K., et al. Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. J. Cereb. Blood Flow Metab. 21 (2001) 351-360
7. Cleveland D.W., Hwo S.Y., and Kirschner M.W. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J. Mol. Biol. 116 (1997) 227-247
8. Cleveland D.W., Hwo S.Y., and Kirschner M.W. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116 (1977) 207-225
9. Drubin D.G., and Kirschner M.W. Tau protein function in living cells. J. Cell Biol. 103 (1986) 2739-2746
10. Lindwall G., and Cole R.D. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J. Biol. Chem. 259 (1984) 5301-5305
11. Matus A. Stiff microtubules and neuronal morphology. Trends Neurosci. 17 (1994) 19-22
12. Yamamoto H., Saitoh Y., Fukunaga K., Nishimura H., and Miyamoto E. Dephosphorylation of microtubule proteins by brain protein phosphatases 1 and 2A, and its effect on microtubule assembly. J. Neurochem. 50 (1988) 1614-1623
13. Buée L., Bussiere T., Buee-Scherrer V., et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33 (2000) 95-130
14. Billingsley M.L., and Kincaid R.L. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J. 323 Pt 3 (1997) 577-591
15. Burkhart K.K., Beard D.C., Lehman R.A.W., et al. Alteration in tau phosphorylation in rat and human neocortical brain slices following hypoxia and glucose deprivation. Exp. Neurol. 154 (1998) 464-472
16. Mailliot C., Podevin-Dimster V., Rosenthal R.E., et al. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion. J. Cereb. Blood Flow Metab. 20 (2000) 543-549
17. Shackelford D.A., and Yeh R.Y. Dephosphorylation of tau during transient forebrain ischemia in the rat. Mol. Chem. Neuropathol. 34 (1998) 103-120
18. Wen Y., Yang S., Liu R., et al. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J. Biol. Chem. 279 (2004) 22684-22692
19. Wen Y., Yang S., Liu R., et al. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res. 1022 (2004) 30-38
20. Ikeda K., Akiyama H., Arai T., et al. Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain?. Neurosci. Lett. 284 (2000) 187-189
21. Shi J., Yang S.H., Stubley L., et al. Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res. 853 (2000) 1-4
22. Contois J.H., Anamani D.E., and Tsongalis G.J. The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorder, cardiovascular disease, and Alzheimer's disease. Clin. Lab. Med. 16 (1996) 105-123
23. Snyder E.L., and Dowdy S.F. Protein/peptide transduction domains: potential to deliver large DNA molecules into cells. Curr. Opin. Mol. Ther. 3 (2001) 147-152
24. Yamamoto H., Hasegawa M., Ono T., et al. Dephosphorylation of fetal-tau and paired helical filaments-tau by protein phosphatases 1 and 2A and calcineurin. J. Biochem. (Tokyo) 118 (1995) 1224-1231
25. Noble W., Olm V., Takata K., et al. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38 (2003) 555-565
26. Alvarez A., Munoz J.P., and Maccioni R.B. A cdk5-p35 stable complex involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. Exp. Cell Res. 264 (2001) 266-274
27. Hashiguchi M., Saito T., Hisanaga S.I., et al. Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau. J. Biol. Chem. 277 (2002) 44525-44530
28. Liu F., Iqbal K., Grundke-Iqbal I., et al. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. FEBS Lett. 530 (2002) 209-214
29. Lund E.T., McKenna R., Evans D.B., et al. Characterization of the in vivo phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry. J. Neurochem. 76 (2001) 1221-1232
30. Michel G., Mercken M., Murayama M., et al. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p25) transfected cells. Biochem. Biophys. Acta 1380 (1998) 177-182
31. Lew J., Huang Q.Q., Qi Z., et al. A brain-specific activator of cyclin-dependent kinase 5. Nature 371 (1994) 423-426
32. Tsai L., Dellale I., and Caviness Jr. V.S. P35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371 (1994) 419-423
33. Green S.L., Kulp K.S., and Vulliet R. Cyclin-dependent protein kinase 5 activity increases in rat brain following ischemia. Neurochem. Int. 31 (1997) 617-623
34. Nath R., Davis M., Probert A.W., et al. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. Biochem. Biophys. Res. Commun. 274 (2000) 16-21
35. Kennedy S.G., Wagner A.J., Conzen S.D., et al. The PI-3kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11 (1997) 701-713
36. Kulik G., Kippel A., and Weber M.J. Antiapoptic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17 (1997) 1595-1606
37. Cross D.A., Alessi D.R., Cohen P., et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
38. Moule S.K., Welsh G.I., Edgell N.J., et al. Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanism. J. Biol. Chem. 272 (1997) 7713-7719